PHARMAKURE LIMITED

Dissolved Sale

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PHARMAKURE LIMITED

Research and experimental development on biotechnology

Founded 5 Jan 2012 Dissolved Sale, United Kingdom 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 31 Oct 2025 8 months overdue
Confirmation Submitted 15 Jan 2025 Next due 23 Jan 2026 5 months overdue
Net assets £-2M £677K 2023 year on year
Total assets £2M £432K 2023 year on year
Total Liabilities £5M £245K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Stamford House Northenden Road Sale Cheshire M33 2DH

Website

www.example.com

Full company profile for PHARMAKURE LIMITED (07898244), a dissolved life sciences and medical technology company based in Sale, United Kingdom. Incorporated 5 Jan 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Feb → 31 Jan 2024
Type total-exemption-full
Next accounts 31 Jan 2025
Due by 31 Oct 2025 8 months overdue

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£44.62k

Decreased by £253.02k (-85%)

Net Assets

-£2.37M

Decreased by £676.79k (-40%)

Total Liabilities

£4.68M

Increased by £244.84k (+6%)

Turnover

N/A

Employees

3

Debt Ratio

203%

Increased by 41 (+25%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Jan Year End
2023
31 Jan Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 650 Shares £650 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Jul 2021650£650£650

Officers

Officers

1 active 2 resigned
Status
Khan, Mohammad Farid, Dr.DirectorBritishEngland555 Jan 2012Active

Shareholders

Shareholders (16)

The University Of Manchester
20.4%
Farid Mohammad Khan
17.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Mohammad Farid Khan

British

Active
Notified 19 Jul 2019
Residence England
DOB November 1970
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Professor Andrew James Doig

Ceased 19 Jul 2019

Ceased

Mohammed Farid Kahn

Ceased 19 Jul 2019

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Apr 2026GazetteGazette Dissolved Liquidation
20 Aug 2025InsolvencyLiquidation In Administration Progress Report
26 Apr 2025InsolvencyLiquidation In Administration Extension Of Period
19 Mar 2025InsolvencyLiquidation In Administration Result Creditors Meeting
12 Mar 2025InsolvencyLiquidation In Administration Proposals
27 Apr 2026 Gazette

Gazette Dissolved Liquidation

20 Aug 2025 Insolvency

Liquidation In Administration Progress Report

26 Apr 2025 Insolvency

Liquidation In Administration Extension Of Period

19 Mar 2025 Insolvency

Liquidation In Administration Result Creditors Meeting

12 Mar 2025 Insolvency

Liquidation In Administration Proposals

Recent Activity

Latest Activity

Gazette Dissolved Liquidation

1 months ago on 27 Apr 2026

Liquidation In Administration Progress Report

9 months ago on 20 Aug 2025

Liquidation In Administration Extension Of Period

1 years ago on 26 Apr 2025

Liquidation In Administration Result Creditors Meeting

1 years ago on 19 Mar 2025

Liquidation In Administration Proposals

1 years ago on 12 Mar 2025